Smallpox vaccine get to a populated place. The world health system is completely unprepared for this." In the United Kingdom, controversy occurred regarding the company which had been contracted to supply the vaccine. This was because of the political connections of its owner, Paul Drayson, and questions over the choice of vaccine strain. The strain was different from that used in the United States. Plans for mass vaccinations in the United States stalled as the necessity of the inoculation came into question. Smallpox vaccine Smallpox vaccine, the first successful vaccine to be developed, was introduced by Edward Jenner in 1796. He followed
Smallpox the United States and South Africa a much milder form of smallpox, "variola minor", was recognized just before the close of the 19th century. By the mid-20th century "variola minor" occurred along with "variola major", in varying proportions, in many parts of Africa. Patients with "variola minor" experience only a mild systemic illness, are often ambulant throughout the course of the disease, and are therefore able to more easily spread disease. Infection with "v. minor" induces immunity against the more deadly "variola major" form. Thus as "v. minor" spread all over the USA, into Canada, the South American countries and